14th Swiss Course on Medicinal Chemistry 2021, Leysin
POSTPONED to October 9-14, 2022

Due to the uncertain situation around the Corona pandemic and the possible restrictions for international travel next fall, the organizing committee has decided to postpone the course to October 2022. We hope to be able to run the course in the fall of 2022 without any restrictions on-site.

This five-day Medicinal Chemistry School that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.

In the beautiful and scenic village of Leysin, close to Lake Geneva, more than 100 young scientists are expected to meet with app. 35 international renowned expert speakers and instructors.

As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistry, pharmacy, pharmacology, or biophysics from the pharmaceutical and biotech industry. Given the broad spectrum and the timeliness of scientific topics discussed, the course also provides a valuable opportunity for advanced medicinal chemists to get acquainted with most recent developments in e.g. the medicinal chemistry of novel target families, novel compound classes, and most modern optimization paradigms. In addition, a number of PhD students and postdocs will be able to attend to receive a broad overview on scientific disciplines involved in modern drug discovery.

The upcoming event will thematically be structured along key topics of strategic relevance for medicinal chemistry that will be presented by opinion leaders in the field. The teaching content will further be intensified by hands-on tutorials in which the theoretical learning’s can immediately be applied to real life problems of pre-clinical drug discovery.


Dr. Gerhard Müller, Gotham Therapeutics

Prof. Dr. Beat Ernst, University of Basel


Dr. Gerhard Müller, Gotham Therapeutics

Dr. Katarzyna Borsuk

Organized by:

 Supported by:

Conference Office

Dr. Kasia Borsuk


SCS Head Office

+41 31 306 92 92